Analyst Ratings for Denali Therapeutics Inc. (DNLI)

DNLI Rating Summary

DNLI Price Target Summary

* Over Last 12-Mos
  |   Expand Research on DNLI
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $70.50 (+37.6%) * Over Last 12-Mos
Rating Score: 8.3 / 10   Percentile Rank: 85%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/10/2021 Cantor Fitzgerald Charles C. Duncan Upgrade Overweight
(Neutral)
105.00
(N/A)
76.96
(51.25)
-33.41% Details
10/16/2020 BTIG Thomas Shrader Downgrade Neutral
(Buy)
N/A
(N/A)
43.51
(51.25)
17.79% Details
Like DNLI Ratings? Also take a look at RUBY, AXLA, MRNA, MCRB

DNLI Ratings News